The study aimed to evaluate the effectiveness of the low-frequency magnetic therapy with a "running" magnetic field in medical rehabilitation after COVID-19 pneumonia.

Materials and research methods: The study included 42 patients (24 men and 18 women) aged 40 to 65 years, who had pneumonia (J16.8) caused by the new coronavirus SARS-CoV-2. The first group included 22 patients who received standard drug therapy and starting from the 20th day after discharge from the hospital, this group of patients received low-frequency magnetotherapy with a “running” pulsed magnetic field of the ALMAG-02 apparatus. The second group included 20 patients who received the same treatment, except for magnetotherapy.

Results: The course of rehabilitation measures carried out led to an increase in the functional capabilities of the cardio-respiratory system in patients of both groups, an increase in chest excursions, an increase in the vital capacity of the lungs, the normalization of the act of breathing and ventilation of the lungs, and an improvement in the psychosomatic status of patients. In the main group, these changes are more pronounced than in the control group, which is associated with the inclusion in the complex treatment of low-frequency magnetotherapy with a “running” pulsed magnetic field.

Conclusion: The use of low-frequency magnetic therapy with a "running" pulsed magnetic field in the complex of rehabilitation measures for patients who have suffered from COVID-19 pneumonia significantly improves the somatic status of patients, increases exercise tolerance, and optimizes the function of external respiration.

Keywords: magnetotherapy, COVID-19, pneumonia